ORIGINAL RESEARCH ARTICLE Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

The Author(s) 2015. This article is published with open access at Springerlink.com Background Sorafenib might prevent hepatocellular car-cinoma (HCC) recurrence caused by the promotion of neoangiogenesis after transarterial chemoembolization (TACE). Objectives To evaluate the efficacy and safety of TACE followed by sorafenib for treating advanced HCC. Patients and Methods We retrospectively analyzed 95 advanced HCC patients treated with TACE between Jul